Nan (LN) Li bought $20.0M of Odyssey Therapeutics (ODTX)

Executed May 11, disclosed May 12, the same day.

Value, as filed

$20.0M

1,111,111 sh × $18.00

Executed

May 11

the trade date, as filed

Disclosed

May 12

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+3.2%

+3.2% from execution

Over the 21 trading sessions from the disclosed entry session (May 11), the stock returned +3.2% (delay-adjusted); from the execution session (May 11), +3.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

NL Nan (LN) Li Director profile →

Nan (LN) Li (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in ODTX. Across 1 priced purchase filing, the average 21-session return was +3.2% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of ODTX (1,111,111 sh × $18.00, as filed), executed May 11.

The name

ODTX ODTX ODTX · 6 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→